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Abstract
Background: Measuring progress towards Millennium Development Goal 6, including estimates of, and time trends in, the
number of malaria cases, has relied on risk maps constructed from surveys of parasite prevalence, and on routine case
reports compiled by health ministries. Here we present a critique of both methods, illustrated with national incidence
estimates for 2009.
Methods and Findings: We compiled information on the number of cases reported by National Malaria Control Programs in
99 countries with ongoing malaria transmission. For 71 countries we estimated the total incidence of Plasmodium
falciparum and P. vivax by adjusting the number of reported cases using data on reporting completeness, the proportion of
suspects that are parasite-positive, the proportion of confirmed cases due to each Plasmodium species, and the extent to
which patients use public sector health facilities. All four factors varied markedly among countries and regions. For 28
African countries with less reliable routine surveillance data, we estimated the number of cases from model-based methods
that link measures of malaria transmission with case incidence. In 2009, 98% of cases were due to P. falciparum in Africa and
65% in other regions. There were an estimated 225 million malaria cases (5th–95th centiles, 146–316 million) worldwide, 176
(110–248) million in the African region, and 49 (36–68) million elsewhere. Our estimates are lower than other published
figures, especially survey-based estimates for non-African countries.
Conclusions: Estimates of malaria incidence derived from routine surveillance data were typically lower than those derived
from surveys of parasite prevalence. Carefully interpreted surveillance data can be used to monitor malaria trends in
response to control efforts, and to highlight areas where malaria programs and health information systems need to be
strengthened. As malaria incidence declines around the world, evaluation of control efforts will increasingly rely on robust
systems of routine surveillance.
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Knowing the number of malaria cases that occur annually in
any country is an essential component of planning national health
services and evaluating their effectiveness. Reliable data from each
endemic country are needed to assess progress globally towards the
United Nations Millennium Development Goals. At present there
are broadly two approaches to estimating malaria incidence
country by country. One method uses routine surveillance reports
of malaria cases compiled by health ministries, adjusted to take
into account incomplete case detection by health facilities, the
potential for overdiagnosis of malaria among patients with fevers,
and the way patients use public and private health services [1].
The second, cartographic method uses population-based surveys
of parasite prevalence and case incidence from selected locations
to generate, by extrapolation, risk maps (i.e., maps of case
incidence per 1,000 population) across malaria endemic regions of
the world. This second method is favoured by the Malaria Atlas
Project (MAP) [2–8]. A major challenge for malaria epidemiol-
ogists is to evaluate the strengths and weaknesses of both methods
in estimating malaria incidence and time trends, especially as
malaria control programmes are intensified worldwide. Other
related work has focused on the subset of cases that are relatively
severe (e.g., severe malarial anaemia, cerebral malaria, neurolog-
ical sequelae) [9] and on deaths due to malaria, and is not
discussed further here.
The most recent presentation of estimates made primarily by
cartography (from MAP) [4] gives point estimates of 271 million P.
falciparum malaria cases in 47 countries on the African continent
and 180 million P. falciparum cases in other countries during 2007.
Those estimates were based on national case reports from seven
countries, and on risk maps for 80 countries. Here we present
another assessment of the worldwide distribution of malaria
incidence, for 2009, using a combination of routinely collected
case reports (for 65 countries, mainly outside Africa) and risk maps
(for 34 countries with less reliable reporting from surveillance
systems, all in Africa), and allowing for the rapid increases in
coverage of insecticide-treated nets since 2005. Compared with
MAP estimates for 2007 [4], our analysis yields lower estimates for
most countries, and especially for several major endemic countries
outside Africa. We discuss the validity of estimates obtained using
the two different approaches, and highlight areas in which both
methods need to be improved to provide better assessments with
which to evaluate efforts to control malaria.
This study includes a critique of methods used to assess the scale
of the malaria problem worldwide, illustrated with estimates
derived by the two principal methods. Besides making some
allowance for vector control, we do not attempt to explain the
geographical and temporal distribution of malaria cases in terms of
the characteristics of vectors, hosts, and environment; that would
require additional data and further work.
Methods
The estimation methods used in this study are described briefly
below and fully in Text S1. Countries are allocated to the six
regions defined by the World Health Organization (WHO).
Estimating the Incidence of Malaria Cases
A case of malaria was defined as fever with Plasmodium infection
(blood smear or rapid diagnostic test [RDT]), which identifies
individuals who require antimalarial treatment. Of the 106
countries most affected by malaria, seven are in WHO’s
‘‘prevention of reintroduction’’ phase during which there is no
local transmission. In this study estimates of the number of malaria
cases were made for each of the 99 countries with ongoing malaria
transmission, by one of two methods.
Method 1: Estimates from routine case reports
(surveillance). Upper and lower limits for the estimated
number of cases, M, arising in any given year in a country are
calculated from:
Mupper~
CzsU
rp
Mlower~
CzsU ðÞ 1{n ðÞ
rp
Where: C=reported number of confirmed malaria cases in a year;
U=reported number of unconfirmed cases in a year: cases
suspected of being malaria but not tested or confirmed, sometimes
known as probable cases; s=the proportion of slides examined
that is positive for malaria parasites (slide positivity rate) or the
proportion of RDTs that gives a positive result; r=completeness of
health-facility reports. This is the number of outpatient health-
facility reports received divided by the number of facility reports
expected. The expected number of reports is the number of health
facilities multiplied by the number of reports expected to be
submitted by each health facility in a year, which is 12 for a
monthly reporting system; p=the proportion of the population
with fever (or suspected malaria) that uses health facilities that are
covered by the public health-facility reporting system. This was
derived from household survey data describing whether or not
children under 5 y, with fever in the previous 2 wk, sought
treatment and where. The household survey used for most
countries was a Demographic and Health Survey (DHS) or
Multiple Indicator Cluster Survey (MICS); n=the proportion of
fever cases (or suspected malaria) that do not seek treatment. This
was derived from household survey data, as for p.
Values of C, U, n, p, r, and s are given for each country in Table 1
and Text S1. Figure 1 shows the distribution of confirmed cases
worldwide, for the lowest administrative level possible in each
country (typically, administrative level 1 in Africa, but down to
administrative level 5 in Brazil). The difference between upper and
lower limits of M reflects the extent to which malaria cases are
treated in the health system, both formal and informal. The upper
limit is an estimate of the number of malaria cases assuming the
same slide positivity rate, s, among those who do and do not seek
treatment. The lower limit estimates the number of malaria cases if
only those fever cases that seek treatment have malaria (i.e., s=0
for fever cases not seeking treatment). In practice the true value
will probably lie between these points. It will lie close to the lower
limit in areas where accessibility to services is good and all cases
that need treatment actually seek it. It will lie closer to the upper
limit in areas where accessibility of services is poor, and many
malaria cases go untreated. In the absence of detailed information
on the structure of health services in a country, we derived a single
point estimate, M, from the arithmetic of average of Mlower and
Mupper. Method 1 was used for all 56 non-African malaria endemic
countries, and for nine African countries for which the quality of
data were considered adequate.
Method 2: Estimates from parasite surveys and risk
maps. This method was used for 34 countries in sub-Saharan
Africa where transmission is relatively homogenous and a broad
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transmission is possible.
The annual incidence of malaria was estimated in two steps.
First, populations in each country were classified as living at either
high, low, or no risk of malaria. Malaria risk for each African
country was defined according to climatic suitability, as per the
Mapping Malaria Risk in Africa (MARA) project estimate for the
year 2002 [2,3]. The proportion of a country’s 2002 population
reported to be living at high, low, and no risk, was applied to the
2009 country populations as projected by the United Nations
Population Division [10]. Second, incidence rates were derived for
populations at high and low transmission risk from a review of
longitudinal studies carried out in populations without malaria
control activities, and these rates were applied to the number of
people living in each risk group (Table 2) [2,3,11].
Because the incidence estimates were for 2002 populations or
earlier, and those populations were not subject to malaria control
measures, the estimates are adjusted downward for each country
according to the expected impact of insecticide treated mosquito
nets (ITNs) by 2009, and also to take account of lower incidence
rates in urban areas [11].
Cases due to P. falciparum. For both methods an estimate
of P. falciparum cases in each country was made by multiplying the
total number of estimated cases by the percentage of cases that
were found to be due to infection with P. falciparum in blood slide
examinations that were carried out by national malaria control
programs. The resulting estimate of the number of cases due to P.
falciparum assumes that the species composition of cases attending
public health facilities reflects that of all cases in the community.
Uncertainty analysis. An underlying distribution was
assumed for each of the parameters used in incidence estimation
(Table 1). Palisade@Risk (version 5.0) was used to sample from the
distributions assumed for each parameter and each country. Latin
Hypercube sampling without replacement was carried out using a
pseudorandom number generator (Mersenne twister). For each
country, we performed 1,000 calculations to yield a plausible
distribution for the annual incidence of malaria cases, summarized
with the mean, and bounded by 5th and 95th centiles.
Results
Malaria Incidence in 2009
Methods 1 and 2 applied to 99 countries together produced a total
estimate of 225 million malaria cases worldwide in 2009 (5th–95th
centiles, 146–315 million) (Table 3).The majority of cases (78%) were
in the WHO African region, followed by the Southeast Asia (15%)
and Eastern Mediterranean regions (5%, Figure 2). In Africa, there
were 214 (133–302) estimated cases per 1,000 population, compared
with 23 (17–34) estimated cases per 1,000 in the Eastern
Mediterranean region and 19 (14–26) estimated cases per 1,000 in
the Southeast Asia region (Table 3). Sixteen countries accounted for
80% of all estimated cases globally, all of them in the African region
except for India and Myanmar (Text S1). The adjustments for
malaria control measures and urban–rural differences reduced the
estimated number of cases by 21% in Africa in 2009.
An estimated 91% or 205 million cases were due to P. falciparum
in 2009; 98% of estimated cases were due to P. falciparum in Africa
and 65% of estimated cases were due to P. falciparum in other
regions (Figure 3, Table 3). The percentage of estimated cases due
to P. falciparum exceeded 75% in all but three countries in the
African region (Algeria, Eritrea, and Ethiopia), but in only 11 out
of 56 countries outside Africa.
Table 1. Distributions assumed for parameters used in method 1.
Parameter Assumed Distribution Description
Parameter derived from reported data
r For each value of reporting completeness,
r was assumed to be distributed as follows:
Reported Value Distribution Minimum Most Likely Maximum
80%+ Triangular 80% 80% 100%
50–80% Uniform 50% — 80%
,50% Triangular 0% 50% 50%
s The uncertainty analysis aimed to reflect the variation of s within a country, so that when s was
applied to cases that were not microscopically examined the slide positivity rate could take on a
range of values that could reasonably be expected to occur across the country. Specifically, the
national slide positivity rate, s, was assumed to be distributed normally with a mean c and
standard deviation of 0.311s
0.5547. Values of s were then truncated so that values lie between 0
and 1. This relationship was obtained from a least squares regression of the mean value of s
against the standard deviation of s for each country for which subnational values of s were
available.
p and np and n were assumed to be distributed normally with mean and standard deviation
derived directly from analysis of household surveys, taking into account the specified
sampling design.
Parameter If parameter imputed
r The reporting rate was assumed to have uniform distribution with a range between
50% and 80%.
s If a country did not report a slide positivity rate, values of s from other countries in the relevant
WHO region were applied and assumed to occur with equal probability.
p and n If a relevant household survey was not available for a country, values of p and n from other
countries in the relevant WHO region were applied and assumed to occur with equal
probability.
doi:10.1371/journal.pmed.1001142.t001
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cases by Method 2.
Age High Transmission Low Transmission Southern Africa
n Median IQR n Median IQR n Median IQR
Under-5s 28 1.424 0.838–2.167 4 0.182 0.125–0.216 5 0.029 0.097–0.129
5–14 y 19 0.587 0.383–0.977 — 0.182
a 0.125–0.216 — 0.029 0.097–0.129
$15 y 7 0.107 0.074–0.138 — 0.091
b 0.063–0.108 — 0.029 0.097–0.129
Urban
Under-5s — 0.712
c 0.419–1.084 — 0.182
d 0.125–0.216 — 0.029 0.097–0.129
5–14 y — 0.587
d 0.383–0.977 — 0.182
d 0.125–0.216 — 0.029 0.097–0.129
$15 y — 0.107
d 0.074–0.138 — 0.091
d 0.063–0.108 — 0.029 0.097–0.129
aNo observations available so assumed to be the same as that measured in children under 5 by Snow et al [3].
bNo observations available so assumed to be half the rate of children 5–14 y by Snow et al [3].
cEstimated to be approximately half the rate of rural areas by Korenromp [11] and Carneiro et al [21].
dConsidered to be the same as in rural areas by Korenromp [11].
IQR, interquartile range.
doi:10.1371/journal.pmed.1001142.t002
Figure 1. Distribution of confirmed malaria cases per 1,000 population, for the lowest administrative level possible in each country.
The number of countries providing data at different administrative levels (from national level 0 down to subnational level 5) were: level 0, 13; level 1,
71; level 2, 19; level 3, 2; level 4, 0; level 5, 1. The total of 106 countries affected by malaria, includes the 99 with ongoing transmission, and seven in
the WHO ‘‘prevention of reintroduction’’ phase. Where national data were incomplete, the whole country is marked as such on the map.
doi:10.1371/journal.pmed.1001142.g001
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95th/5th centiles for country estimates was approximately the
same (geometric mean 2.3 for method 1 and 2.2 for method 2).
Proportion of Cases Detected in 2009
Methods 1 and 2, together with national case reports, also yield
estimates of the percentage of cases detected and confirmed by
malaria control programs. We estimate that 8% of P. falciparum
cases were reported in 99 countries in 2009 (Table 4). These
percentages were #10% in the African, Southeast Asia, Eastern
Mediterranean, and Western Pacific regions and higher in the
American and European regions (Tables 3 and 4).
The overall proportions of cases detected depend on each of the
elements of Model 1, and there were differences among regions in
Table 3. Estimated number of all malaria cases in 2009 and the percentage of estimated cases that were due to infection with P.
falciparum.
WHO Regions Population (m) Estimated Cases P. falciparum (%)
Best
(000s)
Low
(000s)
High
(000s)
Best
(per 1,000)
Low
(per 1,000)
High
(per 1,000)
Africa 821 175,969 109,591 248,178 214 133 302 98
Americas 543 1,132 923 1,439 2 2 3 38
Eastern Mediterranean 523 12,120 8,668 17,816 23 17 34 84
Europe 272 0.64 0.54 0.76 0.0024 0.0020 0.0028 21
Southeast Asia 1,783 33,817 24,993 45,903 19 14 26 58
Western Pacific 1,638 2,257 1,910 2,618 1 1 2 79
World (99 countries) 5,580 225,296 146,085 315,955 40 26 57 91
doi:10.1371/journal.pmed.1001142.t003
Figure 2. Estimated number of malaria cases per 1,000 population in 99 endemic countries made by method 1 (56 non-African and
nine African countries) and method 2 (34 African countries).
doi:10.1371/journal.pmed.1001142.g002
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2009 (Table 5; Text S1). Confirmatory diagnostic tests (blood
slides or RDTs) were used infrequently in Africa (34% of suspected
cases in countries for which we applied method 1) as compared
with other regions (94%, or 82% excluding India). Where
diagnostic tests were done, the percentage positive (s) was less
than 50% in all regions and almost all countries, suggesting that
there is considerable overdiagnosis of malaria where slide-
Figure 3. The percentage of reported malaria cases due to P. falciparum in 99 endemic countries.
doi:10.1371/journal.pmed.1001142.g003
Table 4. A comparison of estimates of P. falciparum malaria cases obtained in this study for 2009 and by the MAP project for 2007.
Regions
Reported P. falciparum
Cases (000s) WHO 2009 MAP 2007
Estimated P. falciparum
cases (000s)
Reported/
Estimated (%)
a
Reported
(000s)
Estimated P. falciparum
Cases (000s)
Reported/
Estimated (%)
b
Africa 1,2799 172,975 7 (7) 71,611 260,994 5
Americas 145 426 34 (50) 788 3,047 5
Eastern
Mediterranean
950 10,153 9 (8) 8,449 13,875 7
Europe 0 0 (96)
c 1.44 0 —
Southeast Asia 1,518 19,588 8 (8) 3,784 154,057 1
Western Pacific 182 1,774 10 (11) 1,946 18,959 1
World (99
countries)
15,594 204,915 8 (8) 86,579 450,932 3
aNumbers in brackets are for P.falciparum and P. vivax combined.
bMAP estimates are compared with reported cases in 2009 because there has been an increase in case reporting since 2007.
cNo cases of P. falciparum were reported in the European region in 2009.
doi:10.1371/journal.pmed.1001142.t004
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European region (r=96%) while information on reporting
completeness was missing for eight out of 21 countries in the
Americas. Southeast Asia had the lowest percentage of malaria
patients that sought treatment in public health facilities (p=14%);
for other regions this percentage was at least 39%. Globally we
estimate that 36% of malaria cases sought treatment in public
sector facilities, while 42% sought treatment from private sector
providers (including physicians, pharmacies, drug stores), and 22%
did not seek treatment at all.
Trends in Malaria Incidence, 2000–2009
The application of these methods for all years from 2000 to
2009 suggests that the number of cases increased worldwide until
2005 and has been falling slowly since then (Table 6, upper panel).
The increase up to 2005 reflects low levels of intervention coverage
in Africa and the effects of population growth. The number of
cases per 1,000 population has been falling slowly in Africa and all
other regions since 2000 (Table 6, lower panel). The estimated
decline in cases per 1,000 population has been fastest in Europe
and the Americas, and has accelerated globally since 2005 (0.5%/
year 2000–2005, 3.2%/year 2005–2009), owing mainly to the
steepening decline in Africa and the Americas.
Discussion
Our estimate of malaria case incidence for the African region is
176 (110–248) million cases in 2009 of which 173 million were
estimated to be due to infection with P. falciparum. This estimate is
lower than the most recent estimate from MAP of 261 (241–301)
million P. falciparum cases in 2007 (Table 4) [4]. The latest MAP
figures are part of a fluctuating series of global estimates from
MAP and WHO: 214 million for year 2000 [3], 365 million for
2002 [5], and 226 million for 2004 [11]. The differences among
these numbers are due primarily to changes in estimation
methods, rather than to changes in malaria epidemiology.
Although our interpretation of method 2 and that of MAP are
based on the same principles, MAP’s estimates [4] are mostly
higher for African countries than ours. We believe that the main
reason for this is that we have allowed for the increasing coverage
of insecticide-treated nets. Without ITNs, our estimate of
incidence in Africa would be 226 (140–318) million cases, of
which an estimated 222 million are due to P. falciparum, and our
estimates would be even closer to MAP’s estimated 261 million
cases in 2007 if our estimates were based on the same data (MAP’s
full dataset is not yet publicly available). The bigger differences,
however, are for non-African countries, where we have relied
more on routine surveillance (estimating 49 million cases, of which
32 million are due to P. falciparum) and MAP has favoured surveys
and risk maps (estimating 190 million P. falciparum cases) (Table 4).
Our estimate of the number of cases due to malaria other than P.
falciparum (20.3 million in Table 3, mainly P. vivax) is also less than
found in some other studies [12,13]. To resolve these discrepan-
cies, we need to consider why estimates based on routine
surveillance might be too low and why those based on surveys
might be too high. The following two sections examine the
strengths and weaknesses of both methods, as implemented in the
present study and previously by MAP.
Estimates Derived from Routine Case Reports
The potential weakness of surveillance-based estimates lies in
the quality of the data that are used to measure five key variables:
reporting completeness (r), the proportion of suspected malaria
cases that is parasite-positive (s), the proportion of malaria cases
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seek treatment (1 2 n), and whether patients use public sector
health facilities (p).
Box 1 lists 12 possible types of error in measuring these variables
and gives possible sources of systematic bias or random error.
Some specific deficiencies in malaria surveillance data have
become clear from the analyses carried out during this study,
and there are broad regional patterns: in Africa, the small
proportion of patients who receive a confirmed diagnosis by
microscopy or RDT; in the Americas, the lack of information on
the number of reports expected and received from health facilities;
in the Eastern Mediterranean, the absence of data on the use of
public and private health facilities; in Southeast Asia, the small
fraction of cases captured by the public health reporting system. In
all regions, there is a risk of underestimating untreated cases of
malaria because mild fevers that might be due to malaria are
missed in household surveys (n is too small and/or p is too large).
As weaknesses in surveillance are recognized and addressed,
estimates will be improved, and the ability of national control
programs to monitor progress and manage resources will be
strengthened. In Southeast Asia, for example, it is clear that
national malaria control programs need to work more closely with
private providers to ensure appropriate diagnosis and treatment
and accurate monitoring. Diagnostic accuracy will improve as
parasitological diagnosis of malaria, including use of RDTs, is
made more widely available and malaria control programs follow
international guidance [14,15]. Routine malaria surveillance
should also serve to reinforce the monitoring and evaluation of
other major diseases including acute respiratory illnesses, diar-
rhoeal diseases, and tuberculosis.
There is also scope to improve the design and coverage of
household surveys in order to assist the interpretation of
surveillance data [16]. Data collected on outpatient and inpatient
attendance rates measured in populations, which can be compared
to the same rates measured from the Health Management
Information System (HMIS), help to assess the completeness of
health facility reporting. We also need to ascertain why fever cases
do not attend health facilities, for example is it because fevers are
mild, or because facilities are geographically inaccessible or
because services are too costly to use (travel costs, fees for users,
and so on). Such information is seldom included in Demographic
and Health Survey (DHS), Multiple Indicator Cluster Survey
(MICS), and Malaria Indicator Surveys though it is sometimes
available in broader health or socio-economic surveys.
In sum, estimates based on surveillance data might be too low or
too high. Having made a checklist of the potential sources of bias
(Box 1), detailed investigations are needed to identify the source
and magnitude of error for each country and measures undertaken
to address deficiencies identified. New guidance on strengthening
surveillance systems for malaria control in different epidemiolog-
ical settings and elimination will be published by WHO during
2012.
Estimates Derived from Surveys and Risk Maps
There are two reasons prima facie why the higher estimates of
case incidence derived from surveys [4] might be too high,
especially for non-African countries. First, the MAP estimates
(based in part on risk maps) imply that surveillance misses a large
fraction of cases, even in countries that have strong health
information systems, and where a relatively high proportion of
cases has signs and symptoms. MAP estimates suggest that the
percentage of cases detected by surveillance was similar for the
Americas and Africa (5%) but, unexpectedly, lower in the
Southeast Asia (1%) and Western Pacific regions (1%) than in
Africa, for the countries that provided data (Table 4). These
detection rates in Asia are far lower than those reported in seven
specific studies on detection cited by MAP [4], which were in the
range 17%–37% (except for India, 2%–11%).
The details of case reporting from specific countries support the
view that MAP estimates are too high. The Vector Borne Disease
Control Programme (VBDCP) in India examined blood slides
from 95.4 million suspected cases in 2009, approximately 8% of
the population, yet detected only 844,000 slides positive for P.
Table 6. Trends in malaria incidence by WHO region and globally, 2000–2009, presented as total number of cases (millions, upper
panel) and cases per 1,000 population (lower panel).
Cases 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Decline Percent/Year
Millions
Africa 173 178 181 185 187 188 187 186 181 176 0.2
Americas 2.8 2.3 2.2 2.1 1.9 1.9 1.7 1.5 1.1 1.1 29.9
Eastern Mediterranean 15 16 17 16 14 12 12 12 13 12 23.6
Europe 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 249.6
Southeast Asia 38 38 35 35 37 39 34 32 34 34 21.4
Western Pacific 2.8 2.5 2.2 2.5 2.8 2.3 2.5 2.1 1.9 2.3 22.6
World 233 236 237 241 243 244 238 233 231 225 20.4
Per 1,000 population
Africa 264 263 262 261 258 253 245 237 225 214 22.2
Americas 5.9 4.8 4.4 4.1 3.8 3.7 3.2 2.7 2.0 2.1 211.2
Eastern Mediterranean 45 44 46 44 39 31 32 30 32 29 25.8
Europe 0.41 0.29 0.23 0.18 0.11 0.06 0.03 0.02 0.01 0.01 250.7
Southeast Asia 24 24 22 21 22 23 20 18 19 19 22.9
Western Pacific 1.8 1.6 1.4 1.6 1.8 1.4 1.6 1.3 1.1 1.4 23.4
World 50 50 49 49 49 48 47 45 44 42 21.8
doi:10.1371/journal.pmed.1001142.t006
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would have to examine 11.3 billion samples from suspected
malaria cases annually to find MAP’s estimated 102 P. falciparum
million cases. This is 9.4 suspected cases per person nationwide. By
the same logic, the number of suspected cases that need to be
examined to obtain MAP estimates in other highly endemic Asian
countries are 9.5 in Viet Nam, 8.5 in Thailand, and 5.2 in
Malaysia. These ratios would be higher still if we considered only
the subpopulations at malaria risk.
Second, MAP’s estimates of P. falciparum case incidence for
many non-African countries are as high as those in Africa. Thus
Myanmar (527/1,000) has a higher estimated incidence rate than
Box 1. Potential Problems and Consequences of Uncertainty in Parameters Used to Estimate Malaria
Cases by Method 1.
Reporting Completeness
Problem 1. Countries may not keep a complete and up-to-
date list of all open health facilities, and reporting
completeness may have been provided only for those
facilities that are known to malaria control programmes.
Consequence: Reporting completeness overestimated and
malaria burden underestimated.
Problem 2. If health facility reports are aggregated at a
district level then, in the absence of other information, when
a district report is received it may be assumed that all health
facilities in the district have reported. Similarly if reports are
aggregated quarterly they may contain incomplete monthly
information but be counted as complete. If accurate
monitoring of the percentage of reports received is not
kept, then reporting completeness may be overestimated.
Consequence: Reporting completeness overestimated and
malaria burden underestimated.
Problem 3. The analysis undertaken does not consider the
type of institution failing to report. Failure of a hospital to
report will generally have a greater influence on the reported
number of malaria cases than a health post. In some
countries malaria programmes have difficulty obtaining data
from hospitals that use a separate reporting system. In other
countries, missing reports may be mostly those from health
posts and reporting completeness underestimated.
Consequence: If hospitals are more likely to underreport, the
reporting completeness will be overestimated. If health posts
are more likely to underreport, reporting completeness will
be underestimated.
Utilization of Public Health Facilities
Problem 4. Demographic and Health Survey (DHS) and
Multiple Indicator Cluster Survey (MICS) were used to estimate
the proportion of malaria cases attending public health facilities,
private health facilities, pharmacies or shops and those not
seeking treatment at all. These proportions were derived from
children under 5 who experienced fever in the 2 wk before the
survey. Care-seeking behaviour in children under 5 seemed to
provide a reasonable approximation to care-seeking behaviour
in other age groups in two countries where it could be checked,
but may not apply elsewhere.
Consequence: There is no comprehensive evidence to
suggest that other age groups use health services more or
less than children under 5 y in response to reported fever.
Potential consequence unknown.
Problem 5. Care-seeking behaviour for self-reported fever
may not necessarily reflect care-seeking behaviour for
suspected or confirmed malaria.
Consequence: There is no comprehensive evidence that fever
differs significantly from true malaria. Potential consequence
unknown.
Problem 6. Only nine of the 69 household surveys analysed
were conducted in 2006. 85% of surveys were from 2000 or
later, with the median age of survey being 5 y. Utilization of
health services may therefore be under- or overestimated.
Consequence: There is no evidence that the percentage of
fever cases using government health services has either
increased or decreased. Potential consequence unknown.
Problem 7. A single national estimate of the proportion of
fever cases attending public health facilities was used. In
some countries, the availability and accessibility of services
may be greater in areas with less malaria. Conversely services
may be less accessible in areas where there is more malaria.
Consequence: Potential overestimation of the proportion of
malaria cases attending public health facilities. Simulta-
neously the proportion of malaria cases using private health
facilities may be overestimated. The combined effect of
these tendencies is unknown.
Problem 8. The uncertainty analysis considered only sampling
variation in the estimation of u and n. The potential effect of
misclassification of treatment outlets as being covered by
the Health Management Information System (HMIS) or not
was not explored.
Consequence: Potential underestimation of the uncertainty
regarding case estimates.
Slide Positivity Rate
Problem 9. Health facilities that undertake slide examination
may only do so for selected patients, e.g., those admitted, or
for adults.
Consequence: If slide examination is reserved for more severe
cases, the number of confirmed malaria cases may be
overestimated. If slide examination is reserved for adults, the
number of confirmed malaria cases may be underestimated.
The combined effect of these tendencies is unknown.
Problem 10. A slide positivity rate (SPR) derived from selected
government facilities is applied to suspected malaria cases
attending other facilities to estimate confirmed malaria
cases. Health facilities not undertaking case confirmation
may differ qualitatively from those undertaking slide
examination (e.g., they may be in different parts of the
country) and obtain a different SPR.
Consequence: If facilities undertaking slide examination are
located in more developed or urban areas, the true
proportion of suspected cases that are confirmed may be
underestimated. If slide examination is more likely to be
undertaken in areas where malaria transmission is more
intense, the proportion of all cases that are confirmed will be
overestimated. The combined effect of these tendencies is
unknown.
Problem 11. A SPR from public health facilities is applied to
private facilities including shops and pharmacies, but the
true rate may be different.
Consequence: No evidence that slide positivity in the private
sector differs from that in the public sector. Potential
consequence unknown.
Problem 12. On average a SPR of half of that found in public
health facilities is applied to fever cases not attending
facilities; the range of SPR used being from 0 to s.
Consequence: Knowledge of infection rates in fever cases that
do not seek treatment is insufficient. Potential consequence
unknown.
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and Chad (all 278); and Malaysia (64) and Philippines (63) are
similar to Ethiopia (72). Comparable incidence rates in these
African and non-African countries seem unlikely not least because
a review of longitudinal studies undertaken by the MAP team
indicates lower malaria incidence rates in non-African settings
than in Africa [8].
There are three further aspects of method 2 that could
overestimate incidence, either in our hands or with the more
sophisticated approaches now used by MAP. First, the surveys of
parasite prevalence and case incidence that determine the spatial
distribution of malaria risk vary in method and purpose. The
surveys were not designed to give unbiased estimates of the
national prevalence of malaria infection. One potential problem is
that parasite prevalence surveys have been carried out in areas of
relatively high malaria incidence. In India, for example, most
surveys have been done in the high incidence areas of Assam and
Orissa [17]. Extrapolating from these sites to populations in
different areas that are at lower risk would lead to overestimates of
case incidence. Overestimates could also arise if surveys were
preferentially done in rural areas where malaria incidence is
typically higher than in urban areas.
The second problem, related to the issues surrounding
prevalence surveys, is that the procedure for delineating areas
with stable malaria tends to overestimate the population at risk
where the administrative unit is large. For China, MAP classified
populations at the second administrative level (prefecture), noting
whether the number of reported P. falciparum cases was more than
1 per 10,000 [6]. Prefectures in Yunnan and Hainan provinces
have a median population size of 2.4 million, and yield a
population at stable risk of malaria (.0.1 case/1,000 population/
year) of 9.3 million. However, if the assessment is done at county
level (median population 280,000), only 3.7 million would be
classified as living in areas with stable malaria, a 2.5-fold
difference.
Third, the latest risk map from MAP is intended to represent
the situation in 2007 [18], but many of the constituent surveys of
parasite prevalence are much older. Of the 7,953 surveys used by
MAP, 41% were done before 2000 [7]. To define the relation
between parasite prevalence and malaria incidence in the African
region, MAP used 25 African surveys (from just six countries), 16
of which were started before 2000 [8]. For non-African countries,
there were 116 surveys, 80 of which were started before 2000.
In addition to these possible sources of bias, other factors affect
uncertainty (Box 2). For example, our use of only two risk
categories is obviously a coarse classification that MAP has refined.
MAP has defined the statistical relation between parasite
prevalence and malaria incidence using Bayesian methods in
order to make best use of prior and posterior information.
However, most of the data points (which constitute the posterior
distribution) that contribute to this analysis lie outside the range of
the 95% credible relationship between incidence and prevalence
[8]. That is, the relation between incidence and prevalence is
highly variable. The implication is that the data have little
influence on the derived relationship malaria incidence and
parasite prevalence, which is strongly determined by prior
assumptions. Consequently, it is not clear for which countries
the MAP statistical model has under- or overestimated incidence.
Finally, our assessment of malaria trends in Africa, which takes
into account only only the impact of ITNs and not other control
measures, might underestimate the rate of decline. We have not
taken into account the use of indoor residual spraying or the
availability of more effective treatment with ACTs. Moreover, it is
well known that factors other than vector control influence
mosquito abundance, species composition, and human biting
rates. These factors include urbanization, trends in rainfall,
temperature, and humidity, changes in land use, and improved
housing construction [19]. To draw a bigger picture of malaria
trends by region and globally requires longer and more reliable
time series of data from a larger number of countries than
currently available. Time trends data are especially limited in the
African region [1,20].
Conclusion
Method 1, based on routine surveillance data, gives lower
estimates of case incidence than method 2, based on population
Box 2. Potential Problems and Consequences
of Uncertainty in Parameters Used to Estimate
Malaria Cases by Method 2.
Problem 1. The delimitation of only two risk categories
(high and low) does not provide for a fine categorization of
malaria risk.
Consequence: A particular risk category may contain a wide
range of malaria incidence and death rates.
Problem 2. The model to determine the suitability of the
climate model for malaria transmission was based on a 30-
y average of climatic variables.
Consequence: There is known to be variation year by year
in the suitability of climate for malaria transmission, and
this annual variation was not taken into account in the
uncertainty analysis, nor was the suitability of the climate
for malaria transmission estimated for specific years.
Problem 3. The studies used to derive basic incidence rates
were not designed to be representative of the levels of
endemicity they purport to describe, are small in number,
and show a wide variation in measured case incidence
with few, if any, studies in urban areas and low-risk rural
areas which required rates to be inferred.
Consequence: If surveys have been done in areas of
relatively high incidence, extrapolating from these sites
to populations at lower risk would lead to overestimates of
case incidence.
Problem 4. The studies used to derive basic incidence rates
within categories of endemicity, urbanicity, and age group
were mostly conducted during the 1990s and earlier when
treatment was often given presumptively in highly
endemic areas (perhaps reducing the incidence of
recurrent malaria), when the malaria case definition may
have differed from that used in this study, and when
incidence rates within endemicity categories may not be
the same as those between 2000 and 2009. Notably, the
influence of artemisinin-based treatments and ITNs on
reducing transmission and case rates was not captured.
Consequence: Current incidence rates might be overesti-
mated (but possibly underestimated) by using historical
data.
Problem 5. The adjustments made to take into account the
effects of interventions on case incidence are based on a
relatively small number of clinical trials, run for only 2 y
after the introduction of ITNs, which tended to show
higher levels of intervention coverage than observed in
most countries. Moreover the assumption of efficacy
varying linearly from lower to higher coverage levels was
not based on empirical evidence.
Consequence: Adjustments based on these trials may give
an optimistic view of the reduction incidence, and
therefore give incidence estimates that are too low.
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ancies for some non-African countries, notably India, will only be
resolved with further data and careful validation.
Although the best assessment of malaria burden and trends
today must rely on a combination of surveillance and survey data,
accurate surveillance is the ultimate goal for malaria control
programs (expanding the database depicted in Figure 1). Routine
surveillance has two particular advantages for estimating case
incidence, spatially and through time. First, data compiled
annually allow for the effects of changes in the array of factors
that influence case incidence from place to place (at the level of
provinces, counties, etc.) and from year to year, especially the
factors linked to climatic variation and malaria control interven-
tions. And the assessment of incidence trends over time is likely to
be more accurate than the assessment of absolute incidence. By
contrast, population surveys cannot be done annually and are
costly when designed to cover whole countries with large enough
samples to detect spatial variation, particularly when parasite
prevalence is low. Second, annual monitoring is an essential part
of running effective control programs, tying budgets and
expenditures to the distribution of commodities and to clinical
and epidemiological outcomes. To strengthen surveillance requires
a critical evaluation of all the types of error we have identified in
this paper. Only with investigations of this kind can we confidently
assess malaria burden and trends, and the return on investments in
control programs.
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Background. Malaria is a life-threatening disease caused by
the Plasmodium parasite, which is transmitted to people
through the bites of infected mosquitoes. According to latest
estimates from the World Health Organization (WHO), in
2009, there were 225 million cases of malaria and an
estimated 781,000 deaths worldwide—most deaths
occurring among children living in the WHO African Region
(mainly sub-Saharan Africa). Knowing the burden of malaria
in any country is an essential component of public health
planning and accurately estimating the global burden is
essential to monitor progress towards the United Nations’
Millennium Development Goals.
Currently, there are generally two approaches used to
estimate malaria incidence:
One method uses routine surveillance reports of malaria
cases compiled by national health ministries, which are
analyzed to take into account some deficincies in data
collection, such as incomplete reporting by health facilities,
the potential for overdiagnosis of malaria among patients
with fever, and the use of private health facilities or none at
all. The second method uses population-based surveys of
Plasmodium prevalence and case incidence from selected
locations in malaria endemic areas and then uses this
information to generate risk maps and to estimate the case
incidence of malaria per 1,000 population, for all of the
world’s malaria endemic regions. The Malaria Atlas Project—
a database of malaria epidemiology based on medical
intelligence and satellite-derived climate data—uses this
second method.
Why Was This Study Done? In order for malaria
epidemiology to be as accurate as possible, an evaluation
of the strengths and weaknesses of both methods is
necessary. In this study, the researchers analyzed the
merits of the estimates calculated by using the different
approaches, to highlight areas in which both methods need
to be improved to provide better assessments of malaria
control.
What Did the Researchers Do and Find? The researchers
estimated the number of malaria cases in 2009, for each of
the 99 countries with ongoing malaria transmission using a
combination of the two methods. The researchers used the
first method for 56 malaria endemic countries outside the
WHO African Region, and for nine African countries which
had the quality of data necessary to calculate estimates
using the researchers statistical model—which the
researchers devised to take the upper and lower limits of
case detection into account. The researchers used the
second method for 34 countries in the African Region to
classify malaria risk into low-transmission and high-
transmission categories, and then to derive incidence rates
for populations from observational studies conducted in
populations in which there were no malaria control activities.
For both methods, the researchers conducted a statistical
analysis to determine the range of uncertainty.
The researchers found that using a combination of methods
there was a combined total of 225 million malaria cases, in
the 99 countries malaria endemic countries—the majority of
cases (78%) were in the WHO African region, followed by the
Southeast Asian (15%) and Eastern Mediterranean regions. In
Africa, there were 214 cases per 1,000 population, compared
with 23 per 1,000 in the Eastern Mediterranean region, and
19 per 1,000 in the Southeast Asia region. Sixteen countries
accounted for 80% of all estimated cases globally—all but
two countries were in the African region. The researchers
found that despite the differences between methods 1 and
2, the ratio of the upper and lower limit for country estimates
was approximately the same.
What Do These Findings Mean? Using the combined
methods, the incidence of malaria was estimated to be lower
than previous estimates, particularly outside of Africa.
Nevertheless the methods suggest that malaria surveillance
systems currently miss the majority of cases, detecting less
than 10% of those estimated to occur globally. Although the
best assessment of malaria burden and trends should rely on
a combination of surveillance and survey data, accurate
surveillance is the ultimate goal for malaria control
programs, especially as routine surveillance has advantages
for estimating case incidence, spatially and through time.
However, as the researchers have identified in this study,
strengthening surveillance requires a critical evaluation of
inherent errors and these errors must be adequately
addressed in order to have confidence in estimates of
malaria burden and trends, and therefore, the return on
investments for malaria control programs.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001142.
N This study is further discussed in a PLoS Medicine
Perspective by Ivo Mueller and colleagues
N The WHO provides information on malaria and produces
the World Malaria Report each year, summarizing global
progress in malaria control
N More information is available on The Malaria Atlas Project
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